These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12434455)

  • 21. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of dialysis in a patient with diabetes and chronic kidney disease.
    McFarland HF
    Nephrol Nurs J; 2005; 32(2):219-20. PubMed ID: 15889806
    [No Abstract]   [Full Text] [Related]  

  • 23. Long 3 x 8 hr dialysis: a three-decade summary.
    Charra B; Chazot C; Jean G; Hurot JM; Vanel T; Terrat JC; VoVan C
    J Nephrol; 2003; 16 Suppl 7():S64-9. PubMed ID: 14733303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sustained low-efficiency dialysis (SLED) in patients with prevalent systolic heart failure refractory to medical treatment and with chronic renal failure].
    Iorio L; Violi F; Simonelli R; Nacca RG; Rossi G; Caliendo A; Lamberti F; Mantella D
    G Ital Nefrol; 2006; 23 Suppl 34():S71-3. PubMed ID: 16634000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The London daily/nocturnal hemodialysis study: a review.
    Lindsay RM; Blagg CR
    Nephrol News Issues; 2003 Nov; 17(12):55-8. PubMed ID: 14640011
    [No Abstract]   [Full Text] [Related]  

  • 26. The efficacy of single-needle versus double-needle hemodialysis in chronic renal failure.
    Trakarnvanich T; Chirananthavat T; Ariyakulnimit S; Maneerat P; Chabsuwan S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S196-206. PubMed ID: 17044473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
    Wazny LD; Raymond CB; Lesperance EM; Bernstein KN
    CANNT J; 2008; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for incident renal dialysis in a managed care population.
    Roblin DW; Khoury A; Pisanelli W; Dahar W; Roth M
    Am J Kidney Dis; 2006 Aug; 48(2):205-11. PubMed ID: 16860185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension.
    Agarwal R
    Semin Dial; 2007; 20(5):402-5. PubMed ID: 17897244
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study.
    Russo D; Andreucci M; De Blasio A; Frattolillo P; Andreucci VE
    Semin Nephrol; 2005 Nov; 25(6):431-4. PubMed ID: 16298268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualizing anaemia treatment: a discussion of case histories.
    Muirhead N
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi37-43. PubMed ID: 15958826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal failure: why today's patients live better and longer.
    Chan R; Michelis MF
    Geriatrics; 1996 Jan; 51(1):37-40, 43. PubMed ID: 8543197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
    Dasselaar JJ; Huisman RM; de Jong PE; Burgerhof JG; Franssen CF
    ASAIO J; 2007; 53(3):357-64. PubMed ID: 17515729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible?
    Bossola M; Tazza L; Vulpio C; Luciani G
    Semin Dial; 2008; 21(5):422-30. PubMed ID: 18764802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
    Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
    Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Computer simulation of dialysis efficacy for various modalities of hemodialysis].
    Yamashita AC
    Nihon Jinzo Gakkai Shi; 2013; 55(4):479-84. PubMed ID: 23819371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.